Bone density changes with enzyme therapy for Gaucher disease

By Lebel Ehud   Dweck Altoon   Foldes A. Joseph   Golowa Yosef   Itzchaki Menachem   Zimran Ari   Elstein Deborah  

Journal of Bone and Mineral Metabolism, Vol. 22, Iss. 6, 2004-11 ,pp. : 597-601

Springer Publishing Company

Access to resources Recommend Favorite

Kidney Function and 24-Hour Proteinuria in Patients with Fabry Disease during 36 Months of Agalsidase Alfa Enzyme Replacement Therapy: A Brazilian Experience

By Thofehrn Scheila   Netto Cristina   Cecchin Cláudia   Burin Maira   Matte Ursula   Brustolin Sílvia   Nunes Ane Cláudia Fernandes   Coelho Janice   Tsao Marylin   Jardim Laura   Giugliani Roberto   Barros Elvino José Guardão  

Renal Failure, Vol. 31, Iss. 9, 2009-10 ,pp. : 773-778

Informa Healthcare

Access to resources Recommend Favorite

Splenic Autotransplantation in Gaucher’s Disease

By  

Digestive Surgery, Vol. 17, Iss. 2, 2000-04 ,pp. : 181-182

Karger

Access to resources Recommend Favorite

Chronic Acalculous Cholecystitis: Changes in Patient Demographics and Evaluation Since the Advent of Laparoscopy

By Jones-Monahan Kellie   Gruenberg James C.  

JSLS, Journal of the Society of Laparoendoscopic Surgeons, Vol. 3, Iss. 3, 1999-07 ,pp. : 221-224

Society of Laparoendoscopic Surgeons

Access to resources Recommend Favorite

Renal replacement therapy for stage 5 chronic kidney disease in the Cayman Islands

By Cawich Shamir  

International Urology and Nephrology, Vol. 42, Iss. 2, 2010-06 ,pp. : 461-464

Springer Publishing Company

Access to resources Recommend Favorite